TP53 and squamous cell carcinoma: TP53 mutations were significantly more frequent in adenocarcinoma (χ2 for trend =4.44, P = 0.035), mainly in the mucinous endocervical adenocarcinoma histotype (54%), compared to squamous cell carcinoma and CIN3 (Table 3).